Online Store: Webinar Recordings
Main Storefront

Understanding the Impacts of the DEA's Drug Take-Back Rule - Webinar Recording

Item Options
Sign in for your pricing!
Price: $120.00
Quantity: *

Changes are on the horizon for the way Americans can safely and securely return their medication for environmentally responsible disposal. The U.S. Drug Enforcement Administration (DEA)'s final rule on the collection of controlled substances, such as Oxycontin, Percocet, and Vicodin--released September 9, 2014--will eventually give consumers much greater flexibility as to when, where, and how they can dispose of their unwanted medication. The rule allows manufacturers, distributors, reverse distributors, narcotic treatment programs, retail pharmacies, and hospitals/clinics with a retail pharmacy to voluntarily apply for authorization to and maintain on-site drug collection receptacles and provide mail-back programs. Law enforcement agencies may also continue to collect controlled substances, and may also now offer mail-back programs.

While the rules "go into effect" October 9, 2014, consumers won't be able to start dropping off their medicines right away. State and municipal governments, local law enforcement agencies, state boards of pharmacy, pharmacy retailers, manufacturers, reverse distributors, and a host of other stakeholders will need to take a number of steps to comply with and carry out the rules. This includes everything from modifying individual state pharmacy and drug disposal regulations to securing additional funding to support the expanded drug take-back programs.

Featuring a diverse and dynamic panel of thought leaders and pharmaceutical stewardship experts, this webinar will explore the health, environmental, technical, and financial implications of the new DEA rules for consumers, governments, law enforcement, pharmacies, manufacturers, and reverse distributors. In particular, it will examine the unique challenges and potential solutions to financing the expanded drug take-back opportunities that the new rule allows.


Speaker bios:

Pat Perry is the Director of Environmental Management at CVS Health. She leads the Environmental Department, responsible for compliance across the enterprise. Ms. Perry is well-versed in regulatory requirements applicable to retail under the CWA, CAA, EPCRA, and in particular, requirements for management of retail and pharmaceutical waste under RCRA. Prior to CVS Health, she led the Environmental Department of another major retailer for 15 years. Her experience and talent provide a unique perspective on how to drive successful programs in a retail setting.

Margaret Shield works for the Local Hazardous Waste Management Program in King County, Washington.  Margaret has worked to promote medicine take-back programs and to pass pharmaceutical stewardship legislation since 2008.  She worked to support passage of the Secure & Responsible Drug Disposal Act in 2010, and has been active throughout DEA’s rule-making.  From 2012 to 2013, she was the lead policy staff during development of the King County Board of Health’s Secure Medicine Return regulation.

Ed Gottlieb, Industrial Pretreatment Coordinator at the Ithaca Area Wastewater Treatment Facility, Chairs the Coalition for Safe Medication Disposal in Tompkins County, N.Y.  He organized numerous one day collection events and inventories of returned medications.  He created a series of how-to videos to help others organize collection events.  Ed led the successful effort to establish a county-wide drop box program.  He has been an active member of the national pharmwaste listserv, contributing extensively on the topic of the DEA rule making.


Charlotte Smith is a consultant in the area of pharmaceutical waste management and Senior Regulatory Advisor, PharmEcology Services, a business unit of Waste Management Healthcare Solutions, Inc. (WMHS), a Waste Management company. She founded PharmEcology Associates, LLC in 2000 and sold the company to WMHS in 2009.  She co-founded Capital Returns, Inc., a nationally known pharmaceutical reverse distributor in 1991 and for 10 years served as president and chief regulatory advisor.  Ms. Smith is also  a registered pharmacist.